Elite Pharmaceuticals, Inc. Finance Lease, Right-of-Use Asset, Amortization
Elite Pharmaceuticals, Inc. (ELTP) reported Finance Lease, Right-of-Use Asset, Amortization of $114.79 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-13
- Elite Pharmaceuticals, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $114.79K, a 3.92% decline year-over-year.
- Elite Pharmaceuticals, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $117.91K, a 1.31% decline year-over-year.
- Elite Pharmaceuticals, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $119.47K, a 0.00% increase year-over-year.
- Elite Pharmaceuticals, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $119.47K, a 0.01% decline year-over-year.
- Elite Pharmaceuticals, Inc. finance lease, right-of-use asset, amortization for fiscal 2026 was $476.33K, a 3.10% increase from fiscal 2025.
- Elite Pharmaceuticals, Inc. finance lease, right-of-use asset, amortization for fiscal 2025 was $462.03K, a 894.83% increase from fiscal 2024.
- Elite Pharmaceuticals, Inc. finance lease, right-of-use asset, amortization for fiscal 2024 was $46.44K.
- Elite Pharmaceuticals, Inc. finance lease, right-of-use asset, amortization for fiscal 2020 was $190.81K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $114.79K 10-Q · filed 2026-08-13 | $232.70K derived: sum of 2 quarters · filed 2026-08-13 | $352.17K derived: sum of 3 quarters · filed 2026-08-13 | $471.64K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $117.91K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $237.38K derived: sum of 2 quarters · filed 2026-06-29 | $356.86K derived: sum of 3 quarters · filed 2026-06-29 | $476.33K 10-K · filed 2026-06-29 |
| 2025-12-31 | $119.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-17 | $238.95K derived: sum of 2 quarters · filed 2026-02-17 | $358.42K 10-Q · filed 2026-02-17 | $477.89K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $119.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-14 | $238.95K 10-Q · filed 2025-11-14 | $358.42K derived: sum of 3 quarters · filed 2026-08-13 | $477.89K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $119.47K 10-Q · filed 2026-08-13 | $238.95K derived: sum of 2 quarters · filed 2026-08-13 | $358.42K derived: sum of 3 quarters · filed 2026-08-13 | $477.89K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $119.47K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $238.94K derived: sum of 2 quarters · filed 2026-06-29 | $358.42K derived: sum of 3 quarters · filed 2026-06-29 | $462.03K 10-K · filed 2026-06-29 |
| 2024-12-31 | $119.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-17 | $238.95K derived: sum of 2 quarters · filed 2026-02-17 | $342.56K 10-Q · filed 2026-02-17 | $382.08K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-09-30 | $119.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-14 | $223.09K 10-Q · filed 2025-11-14 | $262.61K derived: sum of 3 quarters · filed 2025-11-14 | |
| 2024-06-30 | $103.61K 10-Q · filed 2025-08-14 | $143.13K derived: sum of 2 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $39.52K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-30 | $46.44K 10-K · filed 2025-06-30 | ||
| 2023-12-31 | $6.92K 10-Q · filed 2025-02-13 | |||
| 2020-03-31 | $332.83K derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-29 | $284.78K derived: sum of 2 quarters · filed 2020-06-29 | $237.44K derived: sum of 3 quarters · filed 2020-06-29 | $190.81K 10-K · filed 2020-06-29 |
| 2019-12-31 | -$48.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | -$95.39K derived: sum of 2 quarters · filed 2020-02-10 | -$142.03K 10-Q · filed 2020-02-10 | |
| 2019-09-30 | -$47.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-12 | -$93.97K 10-Q · filed 2019-11-12 | ||
| 2019-06-30 | -$46.63K 10-Q · filed 2019-08-09 |